BKHA
Black Hawk Acquisition CorpCompany Information
- Company Name
- Black Hawk Acquisition Corp
- CIK
- CIK0002000775
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- BKHA: Nasdaq, BKHAR: Nasdaq, BKHAU: Nasdaq
- Fiscal Year End
- November 30
- Owner Organization
- 03 Life Sciences
- SIC
- 2836
- SIC Description
- Biological Products, (No Diagnostic Substances)
- Ticker
- BKHA
SEC filing data through
Insider Sentiment
- Last purchase
- —
- Last sale
- —
- Shares purchased (TTM)
- 0
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 1,941,594
- Shares outstanding
- 2,124,077
- Ownership
- 91.41%
Earnings Market Reaction
- Filing date
- 2026-10-06
- Price on filing date
- —
- 1-month reaction
- …
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-08-31 | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | 2025-02-28 | 2024-11-30 | 2024-08-31 | 2024-05-31 | 2024-02-29 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Prepaid Expense Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Assets Held In Trust Noncurrent | 26 | 25 | 25 | 24 | 23 | 73 | 73 | 72 | 71 | 70 | - | ||||||
| Assets | 26 | 25 | 25 | 24 | 23 | 74 | 73 | 72 | 71 | 70 | 0 | ||||||
| Deferred Offering Costs | - | - | - | 1 | - | - | - | - | - | - | 0 | ||||||
Liabilities Current | |||||||||||||||||
| Accrued Liabilities And Other Liabilities | - | - | - | 0 | 0 | 0 | - | 0 | - | - | - | ||||||
| Accounts Payable And Accrued Liabilities Current | 0 | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Convertible Notes Payable Current | 2 | 1 | 1 | 1 | 0 | - | - | 0 | - | - | - | ||||||
| Derivative Liabilities Current | - | - | - | - | 0 | - | - | - | - | - | - | ||||||
| Liabilities Current | 2 | 3 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Deferred Compensation Liability Current | 2 | 2 | 2 | 2 | 2 | 2 | - | 2 | - | - | - | ||||||
| Liabilities | 5 | 5 | 5 | 4 | 3 | 3 | 2 | 2 | 2 | 2 | - | ||||||
Commitments And Contingencies Disclosure | |||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | 26 | 25 | 25 | 24 | 23 | 73 | 73 | 72 | 71 | 70 | - | ||||||
Stockholders Equity | |||||||||||||||||
| Common Stock Value | - | 0 | 0 | - | - | - | - | - | - | - | - | ||||||
| Additional Paid In Capital | 0 | 0 | 0 | 0 | - | - | - | - | - | - | 0 | ||||||
| Retained Earnings Accumulated Deficit | -5 | -5 | -5 | -4 | -3 | -3 | -2 | -2 | -2 | -2 | -0 | ||||||
| Stockholders Equity | -5 | -5 | -5 | -4 | -3 | -3 | -2 | -2 | -2 | -2 | -0 | ||||||
| Liabilities And Stockholders Equity | 26 | 25 | 25 | 24 | 23 | 74 | 73 | 72 | 71 | 70 | 0 | ||||||
| Temporary Equity Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | - | - | - | - | - | - | - | - | ||||||
| Temporary Equity Shares Authorized | 450 | 500 | 500 | - | - | - | - | - | - | - | - | ||||||
| Temporary Equity Shares Issued | 2 | 2 | 2 | - | - | - | - | - | - | - | - | ||||||
| Temporary Equity Shares Outstanding | 2 | 2 | 2 | - | - | - | - | - | - | - | - | ||||||
| Temporary Equity Redemption Price Per Share | 12.24 | 11.92 | 11.60 | - | - | - | - | - | - | - | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialBlack Hawk Acquisition Corp (BKHA) — SEC Financial Statements & Analysis
Black Hawk Acquisition Corp (BKHA) is a biological products, (no diagnostic substances) company. Black Hawk Acquisition Corp trades on Nasdaq as: BKHA, BKHAR, BKHAU. Black Hawk Acquisition Corp (BKHA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-08-31, filed with the SEC on 2026-10-06. Based on that filing, Black Hawk Acquisition Corp carries a market cap of $25.17M, a P/E ratio of 66.35x, a P/B ratio of -4.93x, an enterprise value of $26.39M, and an EV/EBITDA multiple of -36.53x. On profitability, it posts a Return on Equity (ROE) of -32.39% and a Return on Assets (ROA) of 5.26%. Per share, it reports EPS of $0.18, diluted EPS of $0.18, free cash flow per share of $-0.26, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -37.66% year-over-year and EPS growth of -56.21% year-over-year. On the balance sheet, it maintains a current ratio of 0.02x, a quick ratio of 0.01x, working capital of $-2.29M, a debt-to-equity ratio of -1.01x, a debt ratio of 0.18, an interest coverage ratio of -1.69x, free cash flow of $-560.07K (TTM), and net debt of $1.50M. Figures sourced from SEC EDGAR.
- Market Cap
- $25.17M
- P/E TTM
- 66.35x
- EPS TTM
- $0.18
- P/B TTM
- -4.93x
- ROE TTM
- -32.39%
- ROA TTM
- 5.26%
- Debt To Equity
- -1.01x
- Free Cash Flow TTM
- $-560.07K
Data as of 2026-08-31 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Black Hawk Acquisition Corp in?
Black Hawk Acquisition Corp (BKHA) operates in the Biological Products, (No Diagnostic Substances) industry.
What exchange does BKHA trade on?
Black Hawk Acquisition Corp (BKHA) trades on the Nasdaq.
When was Black Hawk Acquisition Corp (BKHA)'s most recent SEC filing?
Black Hawk Acquisition Corp (BKHA)'s most recent SEC filing is a Form 10-Q for the period ended 2026-08-31, filed with the SEC on 2026-10-06.
What is BKHA's market cap?
Black Hawk Acquisition Corp (BKHA) has a market capitalization of $25.17M as of 2026-05-31.
What is BKHA's P/E ratio?
Black Hawk Acquisition Corp (BKHA)'s trailing twelve month P/E ratio is 66.35x as of 2026-05-31.
What is BKHA's EPS (earnings per share)?
Black Hawk Acquisition Corp (BKHA)'s trailing twelve month EPS is $0.18 as of 2026-05-31.
What is BKHA's ROE (return on equity)?
Black Hawk Acquisition Corp (BKHA)'s trailing twelve month Return on Equity (ROE) is -32.39% as of 2026-08-31.
What is BKHA's ROA (return on assets)?
Black Hawk Acquisition Corp (BKHA)'s trailing twelve month Return on Assets (ROA) is 5.26% as of 2026-08-31.
What is BKHA's EV/EBITDA?
Black Hawk Acquisition Corp (BKHA)'s trailing twelve month EV/EBITDA is -36.53x as of 2026-05-31.